In particular, serum LRG1 has been identified as a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease [138], psoriasis [65, 139, 140] lupus nephritis [17], rheumatoid arthritis [141–144] and vasculitis [145–149]. This evidence concerns the gene LRG1 and lupus nephritis.